Condition
Ulcer, Gastric
Total Trials
6
Recruiting
3
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 4 (2)
Trial Status
Recruiting3
Enrolling By Invitation1
Unknown1
Active Not Recruiting1
Clinical Trials (6)
Showing 6 of 6 trials
NCT05725967Enrolling By Invitation
Endoscopic Metabolic and Bariatric Therapies
NCT06002906Phase 4Active Not RecruitingPrimary
The Use of Indocyanine Green to Visualize Blood Flow to the Gastrojejunostomy During Bariatric Surgery.
NCT06543316Not ApplicableRecruiting
Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment
NCT04422405Not ApplicableRecruiting
Functional Changes in the Stomach and Esophagus After One Anastomosis Gastric Bypass- OAGB
NCT05320796Phase 4Recruiting
The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass
NCT04845438Not ApplicableUnknownPrimary
Evaluation of Biliary Reflux After Mini-gastric Bypass With Using the Biliary Reflux Index
Showing all 6 trials